First-Line Afatinib 30 Mg Daily and 40 Mg Daily Showed Similar Efficacy in Patients with Stage IV Lung Adenocarcinoma Harboring an Epidermal Growth Factor Receptormutation in Exon 19 or 21

Authors :: Inn-Wen Chong
Mee-Sun Tsai
Min-Sheng Lee
Yen-Chun Chen
M.-S. Huang
Ying-Ming Tsai
J.-Y. Hung
Chih-Jen Yang
J.Y. Ma
Source :: C73. THORACIC ONCOLOGY: OPTIMIZING LUNG CANCER SCREENING, DIAGNOSIS, AND SURGERY.
Publication Year :: 2020
Publisher :: American Thoracic Society, 2020.

Subjects :: Lung
business.industry
Afatinib
First line
medicine.disease
Exon
medicine.anatomical_structure
Epidermal growth factor
medicine
Cancer research
Adenocarcinoma
In patient
Stage iv
business
medicine.drug

Database :: OpenAIRE
Journal :: C73. THORACIC ONCOLOGY: OPTIMIZING LUNG CANCER SCREENING, DIAGNOSIS, AND SURGERY
Accession number :: edsair.doi...........5daf2f7decd3441b3abd29ba34d68c02

Tools